Professional Documents
Culture Documents
Per40-44 - Hematology Quality Control Program
Per40-44 - Hematology Quality Control Program
Quality Management in
Hematology Laboratory.
By Heidi Hanes
1
Patient Safety Monitoring in International Laboratories (SMILE)
Objectives
• At the end of this presentation should be able to:
Recognize the four components of Quality
Assurance.
Recognize how to troubleshoot problems.
Develop own policy for all aspect of quality
assurance.
Understand what is necessary to undertake a
program of Quality Management in Hematology
Laboratory.
3
Patient Safety Monitoring in International Laboratories (SMILE)
5
Patient Safety Monitoring in International Laboratories (SMILE)
Standardization
• Collaboration between groups.
• Test selection
6
PRE-ANALYTICAL
CONTROL
7
Patient Safety Monitoring in International Laboratories (SMILE)
Understanding functionality of
your instrument:
• principles of operation
• startup or daily checks
• shutdown procedure
• normal sights and sounds of the
instrument
• familiarize staff to troubleshooting
manual
8
Patient Safety Monitoring in International Laboratories (SMILE)
Hematology Subsystems
• Consist of 3 subsystems.
Electronic
Fluidic
Pneumatics (pressure and vacuums)
Hydraulics (liquids)
Reagent
9
Patient Safety Monitoring in International Laboratories (SMILE)
10
Patient Safety Monitoring in International Laboratories (SMILE)
Exercise 1
11
Patient Safety Monitoring in International Laboratories (SMILE)
Pre-Analytical Example 1
21-May-2015
13:45
12
Patient Safety Monitoring in International Laboratories (SMILE)
Repeat Background
21-May-2015
14:00
13
Patient Safety Monitoring in International Laboratories (SMILE)
Corrective Action
Repeat Background
21-May-2015
14:30
WBC 0.05 x 10^3/L PASS
15
Patient Safety Monitoring in International Laboratories (SMILE)
16
Patient Safety Monitoring in International Laboratories (SMILE)
Pre-Analytical Example 2
All parameters have a “P” code
Partial Aspiration
18
Patient Safety Monitoring in International Laboratories (SMILE)
19
Patient Safety Monitoring in International Laboratories (SMILE)
20
Patient Safety Monitoring in International Laboratories (SMILE)
Pre-Analytical Example 3
21
Patient Safety Monitoring in International Laboratories (SMILE)
Solutions
• Find the 30psi regulator and adjust to 30
+/-0.2 psi.
• Rerun several bloods and compare to see
if any difference.
• If unable to adjust or error occurs again
call Technical Hot line.
22
Patient Safety Monitoring in International Laboratories (SMILE)
23
Post-Analytical Control
Understanding your
instrument results:
24
Flags
• Can be a letter or symbol that appears to
right of the result.
Manufacturer controlled
Aspiration, Linearity, interference
Laboratory controlled
Critical range
Decision rules
25
26
Codes
• Symbols that appear in place of results
Indicate beyond reportable range +++++
Vote-out of aperture
Unable to calculate result
Clogged flow cell
27
Patient Safety Monitoring in International Laboratories (SMILE)
Messages
• Usually manufacturer messages
• Indicate possible abnormal cells,
clumping, agglutination
• Used to decide on reporting of instrument
vs manual differential or verification of
measured results.
28
Patient Safety Monitoring in International Laboratories (SMILE)
I
W
29
Patient Safety Monitoring in International Laboratories (SMILE)
Patient Results
• Are the results consistent with the
patient’s condition?
• Delta checks
Can be set on instrument or LIS.
Checks against previous result.
Value set by laboratory.
30
H & H Check/Difference
31
Patient Safety Monitoring in International Laboratories (SMILE)
Exercise 2
32
Patient Safety Monitoring in International Laboratories (SMILE)
33
Patient Safety Monitoring in International Laboratories (SMILE)
34
Patient Safety Monitoring in International Laboratories (SMILE)
35
Patient Safety Monitoring in International Laboratories (SMILE)
36
Patient Safety Monitoring in International Laboratories (SMILE)
37
Patient Safety Monitoring in International Laboratories (SMILE)
38
Patient Safety Monitoring in International Laboratories (SMILE)
39
Patient Safety Monitoring in International Laboratories (SMILE)
40
Patient Safety Monitoring in International Laboratories (SMILE)
41
Patient Safety Monitoring in International Laboratories (SMILE)
42
Patient Safety Monitoring in International Laboratories (SMILE)
43
Patient Safety Monitoring in International Laboratories (SMILE)
Analytical Control
44
Patient Safety Monitoring in International Laboratories (SMILE)
INTERNAL QUALITY
CONTROL
45
Patient Safety Monitoring in International Laboratories (SMILE)
46
Patient Safety Monitoring in International Laboratories (SMILE)
Commercial Controls
47
Patient Safety Monitoring in International Laboratories (SMILE)
Commercial Controls
• Assayed vs Non-assayed
• Establishing QC Ranges
48
Patient Safety Monitoring in International Laboratories (SMILE)
Lot–To-Lot Correlations
1. Set up new QC files for each control level of the new lot.
2. Verify the new lot by running each level of control three times
in its respective file.
3. Ensure that the mean values of the control runs fall within the
ranges published on the manufacturer assay.
4. Run each level twice a day for 3-5 days to calculate new
mean values for each analyte.
5. Compare the calculated mean values for each level to the
range specified on the manufacturer assay sheet.
6. If the calculated mean is within range, enter it as the
expected mean.
49
Patient Safety Monitoring in International Laboratories (SMILE)
50
Patient Safety Monitoring in International Laboratories (SMILE)
51
Patient Safety Monitoring in International Laboratories (SMILE)
Exercise 3
52
Patient Safety Monitoring in International Laboratories (SMILE)
QC Example 1
• Know variation of mean 2 fl
• Initial MCV mean – 84 fl
• Historical 2 SD – +/- 4 fl
• Use half known variation accommodate change
1 fl
• What should the mean be?
85
• Established range – 81-89 fl
• Cumulative mean at end of product life should be 85.
53
Patient Safety Monitoring in International Laboratories (SMILE)
81 80 82 84 85 86 83 82 81 83 84 85 83 85 84 83 81 83 85 84 83 85 86 85 84 85 86 83 85 85 84 85 86 86 85 86 85 86 87 86 87 86 87 88 88 89 85 86 87 88 89 86 87 88 89 90 88 89 85.20
54
QC Example 2
• Manufacturer RBC mean – 2.29 x 106
• Manufacturer RBC Range – 2.18-2.40 x 106
• Calculated RBC mean – 2.35 x 106
• Is this mean valid?
• Our 2SD = 0.15 x 106
• Calculated RBC range – 2.20-2.50 x 106
• Yes mean within the expected range.
55
QC Example 3
• Manufacturer Platelet mean – 528 x 103
• Manufacturer Platelet Range – 407- 649x 103
• Calculated Platelet mean – 402x 103
• Is this mean valid?
• No below the expected range.
56
Commercial Control Monitoring
Levey-Jennings Charts
57
Patient Safety Monitoring in International Laboratories (SMILE)
Levey-Jennings QC Charts
58
Patient Safety Monitoring in International Laboratories (SMILE)
Trend
59
Patient Safety Monitoring in International Laboratories (SMILE)
Shift
60
Patient Safety Monitoring in International Laboratories (SMILE)
Bias
61
Patient Safety Monitoring in International Laboratories (SMILE)
62
Patient Safety Monitoring in International Laboratories (SMILE)
QC Policy
63
Patient Safety Monitoring in International Laboratories (SMILE)
64
Patient Safety Monitoring in International Laboratories (SMILE)
65
Patient Safety Monitoring in International Laboratories (SMILE)
Policy Example
• If control out +/-2SD and a second Westgard rule is also
seen
Rerun the control.
If another vial of control is available use it.
No more than 2 control reruns from same vial or new
vial should be made.
If control still out begin troubleshooting do not report
patient results.
Check maintenance log
Check reagent
Check calibration date
66
Patient Safety Monitoring in International Laboratories (SMILE)
Troubleshooting Guideline
• Should have a policy on how to perform
trouble shooting for out of range results.
Instrument vs sample problem
Resolve problem before running patients
• Can create a checklist .
• Can also include a Corrective Action
Flowchart .
67
Patient Safety Monitoring in International Laboratories (SMILE)
Exercises 4
68
Patient Safety Monitoring in International Laboratories (SMILE)
LJ Example 1
69
Patient Safety Monitoring in International Laboratories (SMILE)
LJ Example 2
70
Patient Safety Monitoring in International Laboratories (SMILE)
LJ Example 3
71
Patient Safety Monitoring in International Laboratories (SMILE)
LJ Exercise 4
72
Patient Safety Monitoring in International Laboratories (SMILE)
LJ Example 5
73
Patient Safety Monitoring in International Laboratories (SMILE)
74
Patient Safety Monitoring in International Laboratories (SMILE)
75
Sample Type WBC HGB
Control 1 5.0-10.0 x 103/mm3 12.0-15.0 mg/dL
Control 2 10.0-15.0 x103 /mm3 7.0-10.0 mg/dL
77
Patient Safety Monitoring in International Laboratories (SMILE)
Exercises 5
78
Patient Safety Monitoring in International Laboratories (SMILE)
Patient QC Example 1
Original Result Scheduled rerun
• WBC – 5.5 x 103 /ul • WBC- 5.9 x 103 /ul
• RBC – 3.554 x 106 /ul • RBC – 3.354 x 106 /ul
• Hgb – 12.4 g/dl • 12.0
• Hct – 36.5 % • 33.5 %
• MCV – 85 fl • 84 fl
• Plat – 250.0 x 103 /ul • 268.0 x 103 /ul
79
Patient Safety Monitoring in International Laboratories (SMILE)
Patient QC Example 1
Original Result Repeat Result
• WBC – 5.5 x 103 /ul • WBC- 5.8 x 103 /ul
• RBC – 3.554 x 106 /ul • RBC – 3.254 x 106 /ul
• Hgb – 12.4 g/dl • 12.0
• Hct – 36.5 % • 33.0 %
• MCV – 85 fl • 85 fl
• Plat – 250.0 x 103 /ul • 260.0 x 103 /ul
80
Patient Safety Monitoring in International Laboratories (SMILE)
Patient QC Example 1
Original Result Back-up Result
• WBC – 5.5 x 103 /ul • WBC- 5.8 x 103 /ul
• RBC – 3.554 x 106 /ul • RBC – 3.354 x 106 /ul
• Hgb – 12.4 g/dl • 12.1
• Hct – 36.5 % • 33.5 %
• MCV – 85 fl • 85 fl
• Plat – 250.0 x 103 /ul • 265.0 x 103 /ul
81
Patient Safety Monitoring in International Laboratories (SMILE)
82
Patient Safety Monitoring in International Laboratories (SMILE)
XB – Moving Averages
• Cost effective quality control method.
• Allows for continuous monitoring of system
performance.
• Uses patient samples in conjunction with
other controls.
• Created by Brian S Bull.
• Algorithm evaluates RBC indices.
• Must run either 100/day or 400/week
83
Patient Safety Monitoring in International Laboratories (SMILE)
84
Patient Safety Monitoring in International Laboratories (SMILE)
• Instrument problem
• Calibration
85
Patient Safety Monitoring in International Laboratories (SMILE)
Exercises 6
86
Patient Safety Monitoring in International Laboratories (SMILE)
Parameters used in XB
• MCV – usually direct measurement
87
Patient Safety Monitoring in International Laboratories (SMILE)
88
Patient Safety Monitoring in International Laboratories (SMILE)
XB Troubleshooting Policy
• Moving Average Acceptability
If Then
Moving average parameters agree within the established Proceed with test of patient samples.
limits set
If 5-6 batches fall outside the limit set and cannot be Hold testing of patient samples and run on backup until
explained investigation complete
• Investigation
89
Patient Safety Monitoring in International Laboratories (SMILE)
Example 1
90
Patient Safety Monitoring in International Laboratories (SMILE)
MCV
MCH
MCHC
91
Yes Yes Yes
Yes
No
Yes Yes
No
No
92
Patient Safety Monitoring in International Laboratories (SMILE)
93
Patient Safety Monitoring in International Laboratories (SMILE)
Example 2
94
Patient Safety Monitoring in International Laboratories (SMILE)
MCV
MCH
MCHC
95
Patient Safety Monitoring in International Laboratories (SMILE)
Yes
Hgb
RBC Yes
Yes
No No
Yes
96
Patient Safety Monitoring in International Laboratories (SMILE)
97
Patient Safety Monitoring in International Laboratories (SMILE)
98
Patient Safety Monitoring in International Laboratories (SMILE)
Example 3
99
Patient Safety Monitoring in International Laboratories (SMILE)
MCV
MCH
MCHC
100
Patient Safety Monitoring in International Laboratories (SMILE)
Yes
Yes Yes
No No
101
Patient Safety Monitoring in International Laboratories (SMILE)
Correlation/Comparison
• Instrument to instrument
103
Patient Safety Monitoring in International Laboratories (SMILE)
IQC Recommendations
• A three level commercial control along with a
retained patient control.
• If patient numbers permits add XB to IQC
• Commercial controls
Two levels at beginning, middle and end of
shift
• Retained Patient Controls
At equal times between commercial controls
105
Patient Safety Monitoring in International Laboratories (SMILE)
QC Schedule Example
106
Patient Safety Monitoring in International Laboratories (SMILE)
107
Patient Safety Monitoring in International Laboratories (SMILE)
EXTERNAL QUALITY
CONTROL
108
Patient Safety Monitoring in International Laboratories (SMILE)
109
Patient Safety Monitoring in International Laboratories (SMILE)
110
Patient Safety Monitoring in International Laboratories (SMILE)
SDI Interpretation
111
Patient Safety Monitoring in International Laboratories (SMILE)
Exercises
7
112
Patient Safety Monitoring in International Laboratories (SMILE)
EQA Example 1
MCV
113
Patient Safety Monitoring in International Laboratories (SMILE)
EQA Example 2
Instrument Differential
114
Patient Safety Monitoring in International Laboratories (SMILE)
115
Patient Safety Monitoring in International Laboratories (SMILE)
INVESTIGATIVE ACTIONS AND ROOT CAUSE: Briefly discuss what actions were taken in this
investigation and what you believe is the possible cause.
1. We checked to find out whether there were clerical errors and found out that there was
none.
2. After replacing the flow cell, the EQA specimen which failed were re-run and all were
within range.
The cause of the EQA failure was a faulty flow cell in the CBC/Differential Analyzer.
This was confirmed because after replacing the flow cell the EQA samples were re-run, all
of the values that had previously failed now fell within acceptable limits of intended
results.
116
Patient Safety Monitoring in International Laboratories (SMILE)
EQA Example 3
117
Patient Safety Monitoring in International Laboratories (SMILE)
CV
is
118
Patient Safety Monitoring in International Laboratories (SMILE)
EQA Example 4
RBC Problem
119
Patient Safety Monitoring in International Laboratories (SMILE)
120
Patient Safety Monitoring in International Laboratories (SMILE)
EQA Example 5
Multiple Analyte Problems
121
Patient Safety Monitoring in International Laboratories (SMILE)
122
Patient Safety Monitoring in International Laboratories (SMILE)
123
Patient Safety Monitoring in International Laboratories (SMILE)
125
Patient Safety Monitoring in International Laboratories (SMILE)
References
• Quality Control (QC) Information and Troubleshooting
Guide – Hematology – Beckman Coulter
• The use of retained patient specimens for hematology
quality control. Hackney JR, Cembrowski GS
• An optimized quality control procedure for hematology
analyzers with the use of retained patient specimens.
Cembrowski GS, Lunetzky ES, Patrick CC, Wilson MK
• Establishing Quality Control Means and Standard
Deviation for Hematology Instrument, Streck
• Quality Assurance in Hematology, WHO
126